TY  - JOUR
AU  - Schattenberg, Jörn M
AU  - Lazarus, Jeffrey V
AU  - Newsome, Philip N
AU  - Serfaty, Lawrence
AU  - Aghemo, Alessio
AU  - Augustin, Salvador
AU  - Tsochatzis, Emmanuel
AU  - de Ledinghen, Victor
AU  - Bugianesi, Elisabetta
AU  - Romero-Gomez, Manuel
AU  - Bantel, Heike
AU  - Ryder, Stephen D
AU  - Boursier, Jerome
AU  - Leroy, Vincent
AU  - Crespo, Javier
AU  - Castera, Laurent
AU  - Floros, Lefteris
AU  - Atella, Vincenzo
AU  - Mestre-Ferrandiz, Jorge
AU  - Elliott, Rachel
AU  - Kautz, Achim
AU  - Morgan, Alice
AU  - Hartmanis, Sally
AU  - Vasudevan, Sharad
AU  - Pezzullo, Lynne
AU  - Trylesinski, Aldo
AU  - Cure, Sandrine
AU  - Higgins, Victoria
AU  - Ratziu, Vlad
PY  - 2021
DO  - 10.1111/liv.14825
UR  - http://hdl.handle.net/10668/17185
T2  - Liver international : official journal of the International Association for the Study of the Liver
AB  - Non-alcoholic steatohepatitis (NASH) is a chronic disease that can progress to end-stage liver disease (ESLD). A large proportion of early-stage NASH patients remain undiagnosed compared to those with advanced fibrosis, who are more likely to receive...
LA  - en
KW  - burden of disease
KW  - cost-of-illness analysis
KW  - economic impact
KW  - healthcare resource utilisation
KW  - non-alcoholic steatohepatitis (NASH)
KW  - Adult
KW  - Cost of Illness
KW  - Europe
KW  - France
KW  - Germany
KW  - Humans
KW  - Italy
KW  - Non-alcoholic Fatty Liver Disease
KW  - Spain
KW  - United Kingdom
TI  - Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
TY  - research article
VL  - 41
ER  -